Journal: Pharmaceutics
Article Title: Anti-Fn14 Antibody-Conjugated Nanoparticles Display Membrane TWEAK-Like Agonism †
doi: 10.3390/pharmaceutics13071072
Figure Lengend Snippet: Specific binding of GpL-TNC-TNF to anti-TNF-AuNPs and anti-IL17A-AuNPs. Equal amounts of carboxyl-modified gold nanoparticles (AuNPs; 25 mg/mL) were conjugated with a constant concentration of anti-TNF or anti-IL17A (2 mg/mL). After removal of the excess unbound antibody molecules, the antibody-conjugated AuNPs were incubated with the indicated concentrations of the GpL-TNC-TNF fusion protein for an hour at 37 °C ( A ). Alternatively, increasing concentrations of the two antibodies were used for gold nanoparticle conjugation and were then incubated with a fixed concentration (500 ng/mL) of GpL-TNF-TNC ( B ). After removal of unbound GpL-TNF-TNF molecules, the nonspecific binding values (derived of the anti-IL17A-AuNPs) were subtracted from the corresponding total binding values (derived of the anti-TNF-AuNPs) to obtain specific binding values that were fitted using non-linear regression to a single binding site interaction plot using GraphPad Prism5 software.
Article Snippet: K D values were then calculated with the “nonlinear regression to a one-site specific binding curve” function of GraphPad Prism5.
Techniques: Binding Assay, Modification, Concentration Assay, Incubation, Conjugation Assay, Derivative Assay, Software